Cancer
Researchers at Guangzhou University of Chinese Medicine have made a significant discovery in the field of cancer immunotherapy. A new customized immunomodulator, developed by the team, has been shown to comprehensively reinforce the anti-tumor immunological cascade. This breakthrough has the potential to enhance the efficacy of immunotherapy for cold tumors,
Cancer
Researchers at Amity University Uttar Pradesh have highlighted the critical role of membrane transporters in cancer, noting that their expression is frequently reprogrammed to support enhanced growth, survival, and therapy resistance. These transporters, regulated by the tumor suppressor p53, facilitate the uptake and efflux of nutrients, ions, and drugs, making
Cancer
Research at Chiba University, Japan, has established a connection between Epstein-Barr Virus (EBV) and gastric cancer through the suppression of apoptosis. The study, published in The Journal of Pathology, found that EBV-positive gastric cancers (GCs) exhibit unique carcinogenic pathways that evade apoptosis in the absence of TP53 mutation. The research
Cancer
Research has identified that gastric cancer patients with poor preoperative nutritional status have significantly reduced overall survival rates. The study, conducted at Fujian Medical University, analyzed data from 19,285 patients from 27 global cohorts between 2016 and 2023. The Prognostic Nutritional Index (PNI) and Nutritional Risk Screening 2002 (NRS-2002)
Cancer
Recent research at the First Hospital of Hunan University of Chinese Medicine has shed new light on the potential of metal nanoparticles in cancer diagnosis and treatment. The study, published in the journal Drug Delivery, revealed that metal nanoparticles (MNPs) have unique physicochemical properties that enable precise drug delivery and
Cancer
Researchers at Yuncheng Central Hospital affiliated to Shanxi Medical University have developed a novel prognostic signature for lower-grade gliomas (LGGs) using machine learning and multi-omics data. The study, published in Discover Oncology, identifies cell adhesion molecules (CAMs) as crucial regulators of tumor biology and immune remodeling in LGGs. Key Takeaways:
Cancer
Aurora, Colorado residents may recall the crucial role electronic health records (EHRs) play in patient care. A recent project in an outpatient medical oncology clinic in the Mountain West region of the US demonstrated the effectiveness of implementing EHR alerts to increase naloxone coprescribing rates for patients with cancer at
Cancer
Research has identified a promising method for the early detection of gastric cancer through the analysis of autoantibodies in the blood. According to a study published in Cancer Biomarkers, a combination of IgG and IgA autoantibodies can serve as non-invasive biomarkers for gastric cancer diagnosis, distinguishing it from gastritis and
Cancer
Researchers from the University of Texas MD Anderson Cancer Center have made a significant discovery in the field of cancer therapy, developing a new technique to target collagen in tumors. The study, published in the Proceedings of the National Academy of Sciences, found that a specific type of T cell
Cancer
Recent research conducted at Chengdu Medical College in Sichuan, People's Republic of China, has shed light on the pivotal epigenetic driver of gastric cancer (GC) pathogenesis. The study, published in Cell Biology and Toxicology, highlights the role of N-6-methyladenosine (m(6)A) modification, orchestrated by methyltransferase-like 3 (METTL3)
Cancer
New research highlights the positive impact of Medicaid expansion on cancer outcomes, showing significant improvements in survival rates among individuals with cancer, particularly in rural and high-poverty communities. The study, conducted by a team of researchers led by Christopher J. Johnson at the Cancer Data Registry of Idaho, analyzed data
Cancer
Research at Chiba University, Japan, has established a connection between Epstein-Barr Virus (EBV) and gastric cancer through the suppression of apoptosis. The study, published in The Journal of Pathology, found that EBV-positive gastric cancers (GCs) exhibit unique carcinogenic pathways that evade apoptosis in the absence of TP53 mutation. The research
